<p>iRhythm Technologies（纳斯达克代码：IRTC - 获取免费报告）的股票在覆盖该公司的十五家评级机构中获得了 “适度买入” 的共识评级，Marketbeat 报道。一位研究分析师对该股票给予了卖出建议，两个分析师给予了持有建议，十一位分析师给予了买入建议，还有一位分析师给予了强烈买入建议。在过去一年中，发布报告的分析师对该股票的平均 12 个月目标价格为 206.4286 美元。</p>
<p>获取 <strong>iRhythm Technologies</strong> 的提醒：</p>
<ul>
<li>下一次人工智能热潮的前三大机器人和自动化股票</li>
</ul>
<p>IRTC 最近成为多份分析师报告的主题。摩根大通将 iRhythm Technologies 的目标价格从 190.00 美元上调至 240.00 美元，并在 10 月 31 日的研究报告中给予该公司 “超配” 评级。Loop Capital 在 10 月 31 日的研究报告中将 iRhythm Technologies 的目标价格定为 220.00 美元。Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对 iRhythm Technologies 的 “卖出（d-）” 评级。BTIG Research 在 10 月 31 日的研究报告中将 iRhythm Technologies 的目标价格从 195.00 美元上调至 215.00 美元，并给予该公司 “买入” 评级。最后，Robert W. Baird 在 10 月 10 日的研究报告中将 iRhythm Technologies 的目标价格从 180.00 美元上调至 220.00 美元，并给予该公司 “跑赢大盘” 评级。</p>
<p><strong>阅读我们关于 iRhythm Technologies 的最新研究报告</strong></p>
<h2>iRhythm Technologies 的内部活动</h2>
<ul>
<li>硅谷银行的四只现金持有量巨大的股票</li>
</ul>
<p>在其他 iRhythm Technologies 的新闻中，首席财务官 Daniel G. Wilson 在 10 月 31 日的交易中出售了 8,000 股 iRhythm Technologies 的股票。这些股票以平均价格 207.44 美元出售，总价值为 1,659,520.00 美元。交易后，首席财务官持有该公司 26,470 股股票，价值 5,490,936.80 美元。这笔交易代表其持股减少了 23.21%。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接获取。此外，首席执行官 Quentin S. Blackford 在 11 月 3 日的交易中出售了 14,059 股公司的股票。这些股票以平均价格 182.94 美元出售，总交易额为 2,571,953.46 美元。出售后，首席执行官直接持有公司 164,979 股股票，价值 30,181,258.26 美元。这代表其持股减少了 7.85%。有关此次出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士已出售 24,817 股公司股票，价值 4,741,235 美元。内部人士持有公司股票的比例为 0.68%。</p>
<h2>机构资金流入和流出</h2>
<p>大型投资者最近对该公司的持仓进行了调整。US Bancorp DE 在第三季度将其在 iRhythm Technologies 的持仓增加了 7.8%。US Bancorp DE 现在拥有 1,042 股公司股票，价值 179,000 美元，此前在该期间内增持了 75 股。Ameritas Investment Partners Inc. 在第二季度将其在 iRhythm Technologies 的持仓增加了 2.9%。Ameritas Investment Partners Inc. 现在拥有 3,256 股公司股票，价值 501,000 美元，此前在上个季度增持了 93 股。Alliancebernstein L.P. 在第三季度将其在 iRhythm Technologies 的持仓增加了 0.3%。Alliancebernstein L.P. 现在拥有 37,489 股公司股票，价值 6,448,000 美元，此前在该期间内增持了 95 股。Smartleaf Asset Management LLC 在第三季度将其在 iRhythm Technologies 的持仓增加了 100.0%。Smartleaf Asset Management LLC 现在拥有 198 股公司股票，价值 34,000 美元，此前在该期间内增持了 99 股。最后，加利福尼亚州教师退休系统在第二季度将其在 iRhythm Technologies 的持仓增加了 0.3%。加利福尼亚州教师退休系统现在拥有 28,917 股公司股票，价值 4,452,000 美元，此前在该期间内增持了 99 股。</p>
<h2>iRhythm Technologies 股票上涨 1.1%</h2>
<p>iRhythm Technologies（纳斯达克代码：IRTC - 获取免费报告）周二开盘价为 178.60 美元。该公司的速动比率为 4.50，流动比率为 4.63，债务与股本比率为 5.32。iRhythm Technologies 的 52 周低点为 86.19 美元，52 周高点为 212.00 美元。该股票的 50 日简单移动平均为 177.42 美元，200 日简单移动平均为 166.34 美元。该公司的市值为 57.5 亿美元，市盈率为-110.93，贝塔值为 1.10。</p>
<p>iRhythm Technologies（纳斯达克代码：IRTC - 获取免费报告）最后一次发布季度财报是在 10 月 30 日。该公司报告季度每股收益（EPS）为（0.06）美元，超出分析师的共识预期（0.36）美元 0.30 美元。该公司在本季度的收入为 1.9288 亿美元，而分析师的预期为 1.8475 亿美元。iRhythm Technologies 的股本回报率为-41.86%，净利润率为-7.32%。该公司的季度收入较去年同期增长了 30.8%。去年同期，该公司每股收益为（1.26）美元。作为一个整体，股票研究分析师预测 iRhythm Technologies 在当前财年将发布-1.98 的每股收益。</p>
<h2>关于 iRhythm Technologies</h2>
<p>（获取免费报告）</p>
<p>iRhythm Technologies, Inc 是一家医疗科技公司，开发和商业化可穿戴心脏监测设备及相关数据分析服务。公司成立于 2006 年，总部位于加利福尼亚州旧金山，旗舰产品是 Zio®贴片，这是一种隐蔽的、一次性使用的连续心电图记录仪，旨在监测心律长达 14 天。iRhythm 的数字诊断平台结合了生物传感器技术和专有算法，以检测心律失常并简化医生的数据解读。</p>
<p>Zio 服务由心脏病专家和其他医疗提供者开处方，以帮助诊断房颤、心动过缓、心动过速及其他心律失常。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，胜过 iRhythm Technologies</li>
<li>华尔街股票挑选者评选 2026 年第一只股票</li>
<li>特朗普的新 AI 预算刚刚通过——一只股票可能会飙升</li>
<li>[如何] 认领您在 SpaceX 的 IPO 前股份！</li>
<li>现在就抛掉这五只股票！</li>
<li>麦当劳的秘密</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVJUQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVJUQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 iRhythm Technologies 吗？</h2>
<p>在考虑 iRhythm Technologies 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 iRhythm Technologies 并不在名单上。</p>
<p>虽然 iRhythm Technologies 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

IRTC

<p>iRhythm Technologies（纳斯达克代码：IRTC）获得了十五家券商的 “适度买入” 共识评级。分析师的建议包括一项卖出、两项持有、十一项买入和一项强力买入。平均 12 个月目标价为 206.43 美元。最近的分析师报告中，摩根大通将目标价上调至 240 美元，Loop Capital 上调至 220 美元，BTIG Research 上调至 215 美元。内部人士的销售包括首席财务官 Daniel G. Wilson 出售了 8,000 股，首席执行官 Quentin S. Blackford 出售了 14,059 股。该股票开盘价为 178.60 美元，市值为 57.5 亿美元，52 周区间为 86.19 美元至 212.00 美元</p>

<p>Shares of iRhythm Technologies (NASDAQ:IRTC - Get Free Report) have received a consensus rating of &#34;Moderate Buy&#34; from the fifteen ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, eleven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $206.4286.</p>
<div class="lb-trans"><p>iRhythm Technologies（纳斯达克代码：IRTC - 获取免费报告）的股票在覆盖该公司的十五家评级机构中获得了 “适度买入” 的共识评级，Marketbeat 报道。一位研究分析师对该股票给予了卖出建议，两个分析师给予了持有建议，十一位分析师给予了买入建议，还有一位分析师给予了强烈买入建议。在过去一年中，发布报告的分析师对该股票的平均 12 个月目标价格为 206.4286 美元。</p>
</div><p>Get <strong>iRhythm Technologies</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>iRhythm Technologies</strong> 的提醒：</p>
</div><ul>
<li>Top 3 Robotics and Automation Stocks for the Next AI Boom</li>
</ul>
<div class="lb-trans"><ul>
<li>下一次人工智能热潮的前三大机器人和自动化股票</li>
</ul>
</div><p>IRTC has been the subject of a number of analyst reports. JPMorgan Chase &amp; Co. boosted their price objective on shares of iRhythm Technologies from $190.00 to $240.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday, October 31st. Loop Capital set a $220.00 target price on shares of iRhythm Technologies in a research note on Friday, October 31st. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of iRhythm Technologies in a research note on Wednesday, October 8th. BTIG Research lifted their price objective on iRhythm Technologies from $195.00 to $215.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, October 31st. Finally, Robert W. Baird upped their target price on iRhythm Technologies from $180.00 to $220.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, October 10th.</p>
<div class="lb-trans"><p>IRTC 最近成为多份分析师报告的主题。摩根大通将 iRhythm Technologies 的目标价格从 190.00 美元上调至 240.00 美元，并在 10 月 31 日的研究报告中给予该公司 “超配” 评级。Loop Capital 在 10 月 31 日的研究报告中将 iRhythm Technologies 的目标价格定为 220.00 美元。Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对 iRhythm Technologies 的 “卖出（d-）” 评级。BTIG Research 在 10 月 31 日的研究报告中将 iRhythm Technologies 的目标价格从 195.00 美元上调至 215.00 美元，并给予该公司 “买入” 评级。最后，Robert W. Baird 在 10 月 10 日的研究报告中将 iRhythm Technologies 的目标价格从 180.00 美元上调至 220.00 美元，并给予该公司 “跑赢大盘” 评级。</p>
</div><p><strong>Read Our Latest Research Report on iRhythm Technologies</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 iRhythm Technologies 的最新研究报告</strong></p>
</div><h2>Insider Activity at iRhythm Technologies</h2>
<div class="lb-trans"><h2>iRhythm Technologies 的内部活动</h2>
</div><ul>
<li>4 Stocks With Huge Cash Holdings at Silicon Valley Bank</li>
</ul>
<div class="lb-trans"><ul>
<li>硅谷银行的四只现金持有量巨大的股票</li>
</ul>
</div><p>In other iRhythm Technologies news, CFO Daniel G. Wilson sold 8,000 shares of iRhythm Technologies stock in a transaction on Friday, October 31st. The shares were sold at an average price of $207.44, for a total value of $1,659,520.00. Following the transaction, the chief financial officer owned 26,470 shares in the company, valued at $5,490,936.80. This trade represents a 23.21% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, CEO Quentin S. Blackford sold 14,059 shares of the business's stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $182.94, for a total transaction of $2,571,953.46. Following the sale, the chief executive officer directly owned 164,979 shares of the company's stock, valued at $30,181,258.26. This represents a 7.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 24,817 shares of company stock valued at $4,741,235. Insiders own 0.68% of the company's stock.</p>
<div class="lb-trans"><p>在其他 iRhythm Technologies 的新闻中，首席财务官 Daniel G. Wilson 在 10 月 31 日的交易中出售了 8,000 股 iRhythm Technologies 的股票。这些股票以平均价格 207.44 美元出售，总价值为 1,659,520.00 美元。交易后，首席财务官持有该公司 26,470 股股票，价值 5,490,936.80 美元。这笔交易代表其持股减少了 23.21%。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接获取。此外，首席执行官 Quentin S. Blackford 在 11 月 3 日的交易中出售了 14,059 股公司的股票。这些股票以平均价格 182.94 美元出售，总交易额为 2,571,953.46 美元。出售后，首席执行官直接持有公司 164,979 股股票，价值 30,181,258.26 美元。这代表其持股减少了 7.85%。有关此次出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士已出售 24,817 股公司股票，价值 4,741,235 美元。内部人士持有公司股票的比例为 0.68%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Large investors have recently made changes to their positions in the company. US Bancorp DE grew its position in iRhythm Technologies by 7.8% during the third quarter. US Bancorp DE now owns 1,042 shares of the company's stock valued at $179,000 after acquiring an additional 75 shares during the period. Ameritas Investment Partners Inc. lifted its stake in shares of iRhythm Technologies by 2.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 3,256 shares of the company's stock valued at $501,000 after purchasing an additional 93 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of iRhythm Technologies by 0.3% during the 3rd quarter. Alliancebernstein L.P. now owns 37,489 shares of the company's stock worth $6,448,000 after purchasing an additional 95 shares during the period. Smartleaf Asset Management LLC grew its holdings in shares of iRhythm Technologies by 100.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 198 shares of the company's stock worth $34,000 after purchasing an additional 99 shares during the period. Finally, California State Teachers Retirement System raised its holdings in iRhythm Technologies by 0.3% in the second quarter. California State Teachers Retirement System now owns 28,917 shares of the company's stock valued at $4,452,000 after buying an additional 99 shares during the period.</p>
<div class="lb-trans"><p>大型投资者最近对该公司的持仓进行了调整。US Bancorp DE 在第三季度将其在 iRhythm Technologies 的持仓增加了 7.8%。US Bancorp DE 现在拥有 1,042 股公司股票，价值 179,000 美元，此前在该期间内增持了 75 股。Ameritas Investment Partners Inc. 在第二季度将其在 iRhythm Technologies 的持仓增加了 2.9%。Ameritas Investment Partners Inc. 现在拥有 3,256 股公司股票，价值 501,000 美元，此前在上个季度增持了 93 股。Alliancebernstein L.P. 在第三季度将其在 iRhythm Technologies 的持仓增加了 0.3%。Alliancebernstein L.P. 现在拥有 37,489 股公司股票，价值 6,448,000 美元，此前在该期间内增持了 95 股。Smartleaf Asset Management LLC 在第三季度将其在 iRhythm Technologies 的持仓增加了 100.0%。Smartleaf Asset Management LLC 现在拥有 198 股公司股票，价值 34,000 美元，此前在该期间内增持了 99 股。最后，加利福尼亚州教师退休系统在第二季度将其在 iRhythm Technologies 的持仓增加了 0.3%。加利福尼亚州教师退休系统现在拥有 28,917 股公司股票，价值 4,452,000 美元，此前在该期间内增持了 99 股。</p>
</div><h2>iRhythm Technologies Stock Up 1.1%</h2>
<div class="lb-trans"><h2>iRhythm Technologies 股票上涨 1.1%</h2>
</div><p>Shares of NASDAQ:IRTC opened at $178.60 on Tuesday. The company has a quick ratio of 4.50, a current ratio of 4.63 and a debt-to-equity ratio of 5.32. iRhythm Technologies has a 52-week low of $86.19 and a 52-week high of $212.00. The stock's fifty day simple moving average is $177.42 and its 200-day simple moving average is $166.34. The company has a market capitalization of $5.75 billion, a P/E ratio of -110.93 and a beta of 1.10.</p>
<div class="lb-trans"><p>iRhythm Technologies（纳斯达克代码：IRTC - 获取免费报告）周二开盘价为 178.60 美元。该公司的速动比率为 4.50，流动比率为 4.63，债务与股本比率为 5.32。iRhythm Technologies 的 52 周低点为 86.19 美元，52 周高点为 212.00 美元。该股票的 50 日简单移动平均为 177.42 美元，200 日简单移动平均为 166.34 美元。该公司的市值为 57.5 亿美元，市盈率为-110.93，贝塔值为 1.10。</p>
</div><p>iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last posted its quarterly earnings data on Thursday, October 30th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.36) by $0.30. The firm had revenue of $192.88 million during the quarter, compared to analysts' expectations of $184.75 million. iRhythm Technologies had a negative return on equity of 41.86% and a negative net margin of 7.32%.The firm's quarterly revenue was up 30.8% compared to the same quarter last year. During the same quarter last year, the business posted ($1.26) EPS. As a group, equities research analysts forecast that iRhythm Technologies will post -1.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>iRhythm Technologies（纳斯达克代码：IRTC - 获取免费报告）最后一次发布季度财报是在 10 月 30 日。该公司报告季度每股收益（EPS）为（0.06）美元，超出分析师的共识预期（0.36）美元 0.30 美元。该公司在本季度的收入为 1.9288 亿美元，而分析师的预期为 1.8475 亿美元。iRhythm Technologies 的股本回报率为-41.86%，净利润率为-7.32%。该公司的季度收入较去年同期增长了 30.8%。去年同期，该公司每股收益为（1.26）美元。作为一个整体，股票研究分析师预测 iRhythm Technologies 在当前财年将发布-1.98 的每股收益。</p>
</div><h2>About iRhythm Technologies</h2>
<div class="lb-trans"><h2>关于 iRhythm Technologies</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>iRhythm Technologies, Inc is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company's flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm's digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.</p>
<div class="lb-trans"><p>iRhythm Technologies, Inc 是一家医疗科技公司，开发和商业化可穿戴心脏监测设备及相关数据分析服务。公司成立于 2006 年，总部位于加利福尼亚州旧金山，旗舰产品是 Zio®贴片，这是一种隐蔽的、一次性使用的连续心电图记录仪，旨在监测心律长达 14 天。iRhythm 的数字诊断平台结合了生物传感器技术和专有算法，以检测心律失常并简化医生的数据解读。</p>
</div><p>The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders.</p>
<div class="lb-trans"><p>Zio 服务由心脏病专家和其他医疗提供者开处方，以帮助诊断房颤、心动过缓、心动过速及其他心律失常。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than iRhythm Technologies</li>
<li>Wall Street Stockpicker Names #1 Stock of 2026</li>
<li>Trump’s new AI budget just passed — one stock could soar</li>
<li>[How To] Claim Your Pre-IPO Stake In SpaceX!</li>
<li>Drop these 5 stocks now!</li>
<li>The McDonald's Secret</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 iRhythm Technologies</li>
<li>华尔街股票挑选者评选 2026 年第一只股票</li>
<li>特朗普的新 AI 预算刚刚通过——一只股票可能会飙升</li>
<li>[如何] 认领您在 SpaceX 的 IPO 前股份！</li>
<li>现在就抛掉这五只股票！</li>
<li>麦当劳的秘密</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVJUQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=IRTC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in iRhythm Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 iRhythm Technologies 吗？</h2>
</div><p>Before you consider iRhythm Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 iRhythm Technologies 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRhythm Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 iRhythm Technologies 并不在名单上。</p>
</div><p>While iRhythm Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 iRhythm Technologies 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

iRhythm Technologies（纳斯达克股票代码：IRTC）被券商一致推荐为 “适度买入”